Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

May 5, 2016May 6, 2016

Olympus Launches Plasma-Oval Button, a New BPH Surgical Device, in US

News

Olympus announced the U.S. launch of its Plasma-Oval Button for urologic procedures, including minimally invasive surgery to reduce benign prostatic hyperplasia (BPH). The U.S. Food and Drug Administration (FDA)-cleared device uses Olympus’ plasma ... Read more

April 18, 2016April 18, 2016

Singapore Study Finds Continued LUTS and Sexual Dysfunction in BPH Patients After Prostate Surgery

News

Benign prostatic hyperplasia (BPH) patients who underwent prostatic surgery were found to be in poor physical health, with many suffering moderate lower urinary tract symptoms (LUTS) and sexual dysfunction, according to the study, “Health-related quality of life, ... Read more

April 4, 2016April 4, 2016

New Surgical Approach to BPH Treatment, Called Plasma Resection, Recommended for Adoption by NICE

News

Olympus announced that its plasma resection system for the surgical treatment of benign prostatic hyperplasia (BPH) was recently recommended for adoption by the U.K. National Institute of Health and Clinical Excellence (NICE). ... Read more

January 19, 2016January 19, 2016

Nonsurgical BPH Treatment System Getting Ready for Major Upgrade

News

Medifocus recently announced it has engaged Tanaka Kapec Design Group as lead designer for the next generation of the company’s Prolieve thermodilatation system to treat benign prostate hyperplasia (BPH). Prolieve is a transurethral microwave thermotherapy system ... Read more

January 11, 2016January 11, 2016

Severe Lower Urinary Tract Symptoms Linked to Depression

News

Men with severe lower urinary tract symptoms are at higher risk of depression than those with less severe urinary symptoms, according to a study recently published in the International Neurourology ... Read more

December 17, 2015December 17, 2015

Topline Data from BPH Extension Studies Show Safety, Efficacy of Single-Injection Treatment

News

Nymox Pharmaceutical Corp. has announced that its long-term extension prospective double-blind Phase 3 clinical trials of fexapotide triflutate (NX-1207) as a single-injection treatment in benign prostatic hyperplasia (BPH) patients have met their primary ... Read more

December 16, 2015December 16, 2015

Influence of Life Circumstances and Personality on BPH Patients’ Treatment Choice

News

Symptomatic Benign Prostate Hyperplasia (BPH) treatment is influenced less by the patient’s personality and more by his life circumstances, according to the results of a study entitled “Influence of Demography ... Read more

November 6, 2015November 6, 2015

Hansen Medical Reports 1st BPH Procedure Using Magellan Robotic Microcatheter Driver

News

Hansen Medical, Inc., a global leader in intravascular robotics, recently announced the completion of the world’s first clinical procedure using its Magellan Robotic Microcatheter Driver as part of the clinical ... Read more

October 19, 2015October 19, 2015

NICE Report Makes NeoTract’s UroLift System Availability More Likely for BPH Patients in UK

News

NeoTract, Inc., a company dedicated to developing innovative, minimally invasive and clinically effective devices to address unmet needs in the field of urology, has recently welcomed the September announcement by the National ... Read more

October 16, 2015October 16, 2015

Antidepressant Improves Quality of Life in Elderly Patients With BPH and Depression

News

Findings from a recent study published in the International Journal of Clinical and Experimental Medicine suggest that an antidepression medication should be included in the treatment of elderly patients with ... Read more